Trials / Unknown
UnknownNCT05703646
Safety and Clinical Performance of the Yukon Choice PC, Yukon Chrome PC & Yukon Choice Flex Stents in Routine Practice
Safety and Clinical Performance of the Yukon Choice PC, Yukon Chrome PC & Yukon Choice Flex Sirolimus Eluting Bioabsorbable Polymer Stents Systems in Routine Clinical Practice: e-Yukon Global Registry.
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 5,000 (estimated)
- Sponsor
- Translumina GmbH · Industry
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
The goal of this observational study is to collect safety and performance information in the setting of a large-scale clinical registry. Patients meeting the selection criteria will be included, in chronological order of their implantation. This registry does not require any additional procedures, follow-up interventions, or ionizing radiation for patients. The inclusion period is planned to last 2 years, starting in Q1 2023. The study will be complete when data on all patient's follow-up for one year have been collected.
Detailed description
* Prospective, observational, noninterventional, multicenter, international clinical registry * Allocation: consecutively treated patients, non-randomized * Masking: None (open label) * Observational model: Longitudinal * Inclusion period: 2 years * Follow-up period: at 1 year * Study duration: 3 years Patients meeting the selection criteria will be included, in chronological order of their implantation. This registry does not require any additional procedures, follow-up interventions, or ionizing radiation for patients. The inclusion period is planned to last 2 years, starting in Q1 2023. The study will be complete when data on all patient's follow-up for one year have been collected. List of visits: V0: During hospitalization: consultation baseline, data of the intervention and data at discharge V1: consultation at 30 days Follow-Up V2: consultation at 12 months Follow-Up
Conditions
Timeline
- Start date
- 2023-03-30
- Primary completion
- 2026-03-30
- Completion
- 2026-03-30
- First posted
- 2023-01-30
- Last updated
- 2023-11-27
Locations
1 site across 1 country: United Arab Emirates
Source: ClinicalTrials.gov record NCT05703646. Inclusion in this directory is not an endorsement.